- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The siRNA Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global siRNA Drugs size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global siRNA Drugs market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
siRNA Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Without GalNAc-conjugated
With GalNAc-conjugated
Market segment by Application, can be divided into
Genetic Disease
Cancers
Other
Market segment by players, this report covers
Alnylam
Novartis
Sirnaomics
Ribo Life Science
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe siRNA Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of siRNA Drugs, with revenue, gross margin and global market share of siRNA Drugs from 2019 to 2021.
Chapter 3, the siRNA Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and siRNA Drugs market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe siRNA Drugs research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of siRNA Drugs
1.2 Classification of siRNA Drugs by Type
1.2.1 Overview: Global siRNA Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global siRNA Drugs Revenue Market Share by Type in 2020
1.2.3 Without GalNAc-conjugated
1.2.4 With GalNAc-conjugated
1.3 Global siRNA Drugs Market by Application
1.3.1 Overview: Global siRNA Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Genetic Disease
1.3.3 Cancers
1.3.4 Other
1.4 Global siRNA Drugs Market Size & Forecast
1.5 Global siRNA Drugs Market Size and Forecast by Region
1.5.1 Global siRNA Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global siRNA Drugs Market Size by Region, (2016-2021)
1.5.3 North America siRNA Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe siRNA Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific siRNA Drugs Market Size and Prospect (2016-2026)
1.5.6 South America siRNA Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa siRNA Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 siRNA Drugs Market Drivers
1.6.2 siRNA Drugs Market Restraints
1.6.3 siRNA Drugs Trends Analysis
2 Company Profiles
2.1 Alnylam
2.1.1 Alnylam Details
2.1.2 Alnylam Major Business
2.1.3 Alnylam siRNA Drugs Product and Solutions
2.1.4 Alnylam siRNA Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Alnylam Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis siRNA Drugs Product and Solutions
2.2.4 Novartis siRNA Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Sirnaomics
2.3.1 Sirnaomics Details
2.3.2 Sirnaomics Major Business
2.3.3 Sirnaomics siRNA Drugs Product and Solutions
2.3.4 Sirnaomics siRNA Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sirnaomics Recent Developments and Future Plans
2.4 Ribo Life Science
2.4.1 Ribo Life Science Details
2.4.2 Ribo Life Science Major Business
2.4.3 Ribo Life Science siRNA Drugs Product and Solutions
2.4.4 Ribo Life Science siRNA Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Ribo Life Science Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global siRNA Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 siRNA Drugs Players Market Share
3.2.2 Top 10 siRNA Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 siRNA Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global siRNA Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global siRNA Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global siRNA Drugs Revenue Market Share by Application (2016-2021)
5.2 siRNA Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America siRNA Drugs Revenue by Type (2016-2026)
6.2 North America siRNA Drugs Revenue by Application (2016-2026)
6.3 North America siRNA Drugs Market Size by Country
6.3.1 North America siRNA Drugs Revenue by Country (2016-2026)
6.3.2 United States siRNA Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada siRNA Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico siRNA Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe siRNA Drugs Revenue by Type (2016-2026)
7.2 Europe siRNA Drugs Revenue by Application (2016-2026)
7.3 Europe siRNA Drugs Market Size by Country
7.3.1 Europe siRNA Drugs Revenue by Country (2016-2026)
7.3.2 Germany siRNA Drugs Market Size and Forecast (2016-2026)
7.3.3 France siRNA Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom siRNA Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia siRNA Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy siRNA Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific siRNA Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific siRNA Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific siRNA Drugs Market Size by Region
8.3.1 Asia-Pacific siRNA Drugs Revenue by Region (2016-2026)
8.3.2 China siRNA Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan siRNA Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea siRNA Drugs Market Size and Forecast (2016-2026)
8.3.5 India siRNA Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia siRNA Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia siRNA Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America siRNA Drugs Revenue by Type (2016-2026)
9.2 South America siRNA Drugs Revenue by Application (2016-2026)
9.3 South America siRNA Drugs Market Size by Country
9.3.1 South America siRNA Drugs Revenue by Country (2016-2026)
9.3.2 Brazil siRNA Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina siRNA Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa siRNA Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa siRNA Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa siRNA Drugs Market Size by Country
10.3.1 Middle East & Africa siRNA Drugs Revenue by Country (2016-2026)
10.3.2 Turkey siRNA Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia siRNA Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE siRNA Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global siRNA Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global siRNA Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market siRNA Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global siRNA Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global siRNA Drugs Revenue Market Share by Region (2021-2026)
Table 6. Alnylam Corporate Information, Head Office, and Major Competitors
Table 7. Alnylam Major Business
Table 8. Alnylam siRNA Drugs Product and Solutions
Table 9. Alnylam siRNA Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis siRNA Drugs Product and Solutions
Table 13. Novartis siRNA Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sirnaomics Corporate Information, Head Office, and Major Competitors
Table 15. Sirnaomics Major Business
Table 16. Sirnaomics siRNA Drugs Product and Solutions
Table 17. Sirnaomics siRNA Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Ribo Life Science Corporate Information, Head Office, and Major Competitors
Table 19. Ribo Life Science Major Business
Table 20. Ribo Life Science siRNA Drugs Product and Solutions
Table 21. Ribo Life Science siRNA Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global siRNA Drugs Revenue (USD Million) by Players (2019-2021)
Table 23. Global siRNA Drugs Revenue Share by Players (2019-2021)
Table 24. Breakdown of siRNA Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. siRNA Drugs Players Head Office, Products and Services Provided
Table 26. siRNA Drugs Mergers & Acquisitions in the Past Five Years
Table 27. siRNA Drugs New Entrants and Expansion Plans
Table 28. Global siRNA Drugs Revenue (USD Million) by Type (2016-2021)
Table 29. Global siRNA Drugs Revenue Share by Type (2016-2021)
Table 30. Global siRNA Drugs Revenue Forecast by Type (2021-2026)
Table 31. Global siRNA Drugs Revenue by Application (2016-2021)
Table 32. Global siRNA Drugs Revenue Forecast by Application (2021-2026)
Table 33. North America siRNA Drugs Revenue by Type (2016-2021) & (USD Million)
Table 34. North America siRNA Drugs Revenue by Type (2021-2026) & (USD Million)
Table 35. North America siRNA Drugs Revenue by Application (2016-2021) & (USD Million)
Table 36. North America siRNA Drugs Revenue by Application (2021-2026) & (USD Million)
Table 37. North America siRNA Drugs Revenue by Country (2016-2021) & (USD Million)
Table 38. North America siRNA Drugs Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe siRNA Drugs Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe siRNA Drugs Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe siRNA Drugs Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe siRNA Drugs Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe siRNA Drugs Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe siRNA Drugs Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific siRNA Drugs Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific siRNA Drugs Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific siRNA Drugs Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific siRNA Drugs Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific siRNA Drugs Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific siRNA Drugs Revenue by Region (2021-2026) & (USD Million)
Table 51. South America siRNA Drugs Revenue by Type (2016-2021) & (USD Million)
Table 52. South America siRNA Drugs Revenue by Type (2021-2026) & (USD Million)
Table 53. South America siRNA Drugs Revenue by Application (2016-2021) & (USD Million)
Table 54. South America siRNA Drugs Revenue by Application (2021-2026) & (USD Million)
Table 55. South America siRNA Drugs Revenue by Country (2016-2021) & (USD Million)
Table 56. South America siRNA Drugs Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa siRNA Drugs Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa siRNA Drugs Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa siRNA Drugs Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa siRNA Drugs Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa siRNA Drugs Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa siRNA Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. siRNA Drugs Picture
Figure 2. Global siRNA Drugs Revenue Market Share by Type in 2020
Figure 3. Without GalNAc-conjugated
Figure 4. With GalNAc-conjugated
Figure 5. siRNA Drugs Revenue Market Share by Application in 2020
Figure 6. Genetic Disease Picture
Figure 7. Cancers Picture
Figure 8. Other Picture
Figure 9. Global siRNA Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global siRNA Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global siRNA Drugs Revenue Market Share by Region (2016-2026)
Figure 12. Global siRNA Drugs Revenue Market Share by Region in 2020
Figure 13. North America siRNA Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe siRNA Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific siRNA Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America siRNA Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa siRNA Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. siRNA Drugs Market Drivers
Figure 19. siRNA Drugs Market Restraints
Figure 20. siRNA Drugs Market Trends
Figure 21. Alnylam Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Sirnaomics Recent Developments and Future Plans
Figure 24. Ribo Life Science Recent Developments and Future Plans
Figure 25. Global siRNA Drugs Revenue Share by Players in 2020
Figure 26. siRNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 27. Global Top 3 Players siRNA Drugs Revenue Market Share in 2020
Figure 28. Global Top 10 Players siRNA Drugs Revenue Market Share in 2020
Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 30. Global siRNA Drugs Revenue Share by Type in 2020
Figure 31. Global siRNA Drugs Market Share Forecast by Type (2021-2026)
Figure 32. Global siRNA Drugs Revenue Share by Application in 2020
Figure 33. Global siRNA Drugs Market Share Forecast by Application (2021-2026)
Figure 34. North America siRNA Drugs Sales Market Share by Type (2016-2026)
Figure 35. North America siRNA Drugs Sales Market Share by Application (2016-2026)
Figure 36. North America siRNA Drugs Revenue Market Share by Country (2016-2026)
Figure 37. United States siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Canada siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Mexico siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Europe siRNA Drugs Sales Market Share by Type (2016-2026)
Figure 41. Europe siRNA Drugs Sales Market Share by Application (2016-2026)
Figure 42. Europe siRNA Drugs Revenue Market Share by Country (2016-2026)
Figure 43. Germany siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. France siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. United Kingdom siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Russia siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Italy siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Asia-Pacific siRNA Drugs Sales Market Share by Type (2016-2026)
Figure 49. Asia-Pacific siRNA Drugs Sales Market Share by Application (2016-2026)
Figure 50. Asia-Pacific siRNA Drugs Revenue Market Share by Region (2016-2026)
Figure 51. China siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Japan siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South Korea siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. India siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Southeast Asia siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Australia siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South America siRNA Drugs Sales Market Share by Type (2016-2026)
Figure 58. South America siRNA Drugs Sales Market Share by Application (2016-2026)
Figure 59. South America siRNA Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Brazil siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Argentina siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Middle East and Africa siRNA Drugs Sales Market Share by Type (2016-2026)
Figure 63. Middle East and Africa siRNA Drugs Sales Market Share by Application (2016-2026)
Figure 64. Middle East and Africa siRNA Drugs Revenue Market Share by Country (2016-2026)
Figure 65. Turkey siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Saudi Arabia siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. UAE siRNA Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Methodology
Figure 69. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
